This review illustrates how cytokine differences across delivery methods influence postpartum pelvic floor recovery, indicating potential therapeutic targets.
Postpartum pelvic floor dysfunction (PPFD) is a common complication that substantially impairs women’s quality of life, and its pathogenesis is closely associated with the physiological and pathological changes induced by different modes of delivery. As a key regulator of local immunity and tissue repair, the vaginal microenvironment undergoes marked alterations during and after childbirth, particularly in cytokine expression patterns. This review synthesizes current evidence on the differential expression of cytokines-including pro-inflammatory, tissue-repair, and anti-fibrotic mediators-across vaginal delivery, cesarean section, instrumental delivery (forceps or vacuum extraction), and other special circumstances such as multiple gestation and dystocia. It also elucidates the mechanisms through which these cytokines modulate postpartum pelvic floor recovery by regulating inflammation, angiogenesis, collagen remodeling, and mucosal immunity. In addition, the clinical implications for postpartum rehabilitation and emerging research directions centered on cytokine-mediated pathways are discussed. Finally, we propose a novel “immune microenvironment–pelvic floor repair” conceptual model that underscores the potential of vaginal cytokines as biomarkers and therapeutic targets for improving postpartum pelvic floor health
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: